Reviewed,
UniProtKB/Swiss-Prot P63000 (RAC1_HUMAN)
Last modified
November 25, 2008.
Version 68.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Ras-related C3 botulinum toxin substrate 1 Alternative name(s): p21-Rac1 Ras-like protein TC25 Cell migration-inducing gene 5 protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 192 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization and growth-factor induced formation of membrane ruffles. Isoform B has an accelerated GEF-independent GDP/GTP exchange and an impaired GTP hydrolysis, which is restored partially by GTPase-activating proteins. It is able to bind to the GTPase-binding domain of PAK but not full-length PAK in a GTP-dependent manner, suggesting that the insertion does not completely abolish effector interaction. |
| Enzyme regulation | Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP, GTPase activating proteins (GAPs) which increase the GTP hydrolysis activity, and GDP dissociation inhibitors which inhibit the dissociation of the nucleotide from the GTPase. |
| Subunit structure | Interacts with the GEF proteins PREX1, RASGRF2, DOCK1, DOCK2 and DOCK7, which promote the exchange between GDP and GTP, and therefore activate it. Interacts with PARD6A, PARD6B and PARD6G in a GTP-dependent manner. Part of a quaternary complex containing PARD3, some PARD6 protein (PARD6A, PARD6B or PARD6G) and some atypical PKC protein (PRKCI or PRKCZ), which plays a central role in epithelial cell polarization. Found in a trimeric complex composed of DOCK1 and ELMO1, which plays a central role in phagocytosis of apoptotic cells. Interacts with RALBP1 via its effector domain. Interacts with PLXNB1. Part of a complex with MAP2K3, MAP3K3, CCM2 and DEF6. Interacts with BAIAP2, BAIAP2L1, CYFIP1/SRA-1 and DEF6. Interacts with Y.pseudotuberculosis YPKA and PLCB2. Interacts with NOXA1. Interacts with ARHGEF2. Interacts with NISCH By similarity. |
| Subcellular location | Cell membrane; Lipid-anchor; Cytoplasmic sideBy similarity. Melanosome. Note= Inner surface of plasma membrane possibly with attachment requiring prenylation of the C-terminal cysteine By similarity. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. |
| Tissue specificity | Isoform B is predominantly identified in skin and epithelial tissues from the intestinal tract. The expression of isoform B is elevated in colorectal tumors at various stages of neoplastic progression, as compared to their respective adjacent tissues. |
| Domain | The effector region mediates interaction with DEF6. |
| Sequence similarities | Belongs to the small GTPase superfamily. Rho family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Q06409 | 1 | EBI-413628,EBI-35964 | From a different organism. | |
| ARFIP2 | P53365 | 4 | EBI-413628,EBI-638194 | |
| ARHGDIA | P52565 | 1 | EBI-413628,EBI-712693 | |
| DOCK1 | Q14185 | 3 | EBI-413628,EBI-446740 | |
| DOCK2 | Q92608 | 1 | EBI-413628,EBI-448771 | |
| limE | O60952 | 1 | EBI-413628,EBI-1808840 | From a different organism. |
| NCF2 | P19878 | 2 | EBI-413628,EBI-489611 | |
| PAK1 | Q13153 | 3 | EBI-413628,EBI-1307 | |
| Pak1 | O88643 | 1 | EBI-413628,EBI-457240 | From a different organism. |
| Pak3 | Q61036 | 1 | EBI-413628,EBI-457317 | From a different organism. |
| PARD6A | Q9NPB6 | 1 | EBI-413628,EBI-81876 | |
| PARD6B | Q9BYG5 | 1 | EBI-413628,EBI-295391 | |
| PARD6G | Q9BYG4 | 1 | EBI-413628,EBI-295417 | |
| sptP | P74873 | 1 | EBI-413628,EBI-1030433 | From a different organism. |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform A (identifier: P63000-1) Also known as: Rac1A; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform B (identifier: P63000-2) Also known as: Rac1B; Rac1ins; The sequence of this isoform differs from the canonical sequence as follows: 75-75: T → TVGETYGKDITSRGKDKPIA |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 189 | 189 | Ras-related C3 botulinum toxin substrate 1 | PRO_0000042036 | |||||||||||||||||||||||||||||||||||||
| Propeptide | 190 – 192 | 3 | Removed in mature form By similarity | PRO_0000042037 | |||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 10 – 17 | 8 | GTP By similarity | ||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 57 – 61 | 5 | GTP By similarity | ||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 115 – 118 | 4 | GTP By similarity | ||||||||||||||||||||||||||||||||||||||
| Motif | 32 – 40 | 9 | Effector region Potential | ||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||
| Modified residue | 39 | 1 | ADP-ribosylasparagine; by botulinum toxin By similarity | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 189 | 1 | Cysteine methyl ester | ||||||||||||||||||||||||||||||||||||||
| Lipidation | 189 | 1 | S-geranylgeranyl cysteine | ||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 75 | 1 | T → TVGETYGKDITSRGKDKPIA in isoform B. | VSP_005710 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 26 | 1 | N → D: dbSNP rs5830. | VAR_014540 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 28 | 1 | F → L: dbSNP rs5832. | VAR_014541 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 59 | 1 | A → T: dbSNP rs5837. | VAR_014542 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 63 | 1 | D → G: dbSNP rs5831. | VAR_014543 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 93 | 1 | V → G: dbSNP rs5826. | VAR_014545 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 93 | 1 | V → I: dbSNP rs5825. | VAR_014544 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 108 | 1 | T → I: dbSNP rs5838. | VAR_014546 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 130 | 1 | K → R: dbSNP rs5828. | VAR_014547 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 133 | 1 | K → E: dbSNP rs5835. | VAR_014548 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 135 | 1 | T → I: dbSNP rs11540455. | VAR_033303 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 180 | 1 | P → S: dbSNP rs16063. | VAR_014549 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 182 | 1 | V → E: dbSNP rs5836. | VAR_014550 | |||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 12 | 1 | G → V: Constitutively active. Interacts with PARD6 proteins | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 17 | 1 | T → N: Constitutively inactivated. Abolishes interaction with PARD6 proteins | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 37 | 1 | F → A: Strongly reduced interaction with PLCB2 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 56 | 1 | W → A: Strongly reduced interaction with PLCB2 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 61 | 1 | Q → L: Constitutively active. Interacts with PARD6 proteins | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 67 | 1 | L → A: Strongly reduced interaction with PLCB2 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 70 | 1 | L → A: Strongly reduced interaction with PLCB2 | ||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 192 | 1 | Missing in AAA36544. Ref.2 | ||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 4 – 9 | 6 | |||||||||||||||||||||||||||||||||||||||
| Helix | 16 – 25 | 10 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 39 – 46 | 8 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 49 – 56 | 8 | |||||||||||||||||||||||||||||||||||||||
| Helix | 62 – 64 | 3 | |||||||||||||||||||||||||||||||||||||||
| Turn | 65 – 67 | 3 | |||||||||||||||||||||||||||||||||||||||
| Helix | 68 – 71 | 4 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 76 – 83 | 8 | |||||||||||||||||||||||||||||||||||||||
| Helix | 87 – 95 | 9 | |||||||||||||||||||||||||||||||||||||||
| Helix | 97 – 104 | 8 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 110 – 115 | 6 | |||||||||||||||||||||||||||||||||||||||
| Helix | 117 – 120 | 4 | |||||||||||||||||||||||||||||||||||||||
| Helix | 123 – 131 | 9 | |||||||||||||||||||||||||||||||||||||||
| Helix | 139 – 148 | 10 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 152 – 156 | 5 | |||||||||||||||||||||||||||||||||||||||
| Turn | 159 – 161 | 3 | |||||||||||||||||||||||||||||||||||||||
| Helix | 165 – 176 | 12 | |||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Rac, a novel ras-related family of proteins that are botulinum toxin substrates." Didsbury J., Weber R.F., Bokoch G.M., Evans T., Snyderman R. J. Biol. Chem. 264:16378-16382(1989) [PubMed: 2674130] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A). |
| [2] | "Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line." Drivas G.T., Shih A., Coutavas E., Rush M.G., D'Eustachio P. Mol. Cell. Biol. 10:1793-1798(1990) [PubMed: 2108320] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A). |
| [3] | "Small GTPase Rac1: structure, localization, and expression of the human gene." Matos P., Skaug J., Marques B., Beck S., Verissimo F., Gespach C., Boavida M.G., Scherer S.W., Jordan P. Biochem. Biophys. Res. Commun. 277:741-751(2000) [PubMed: 11062023] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS A AND B). |
| [4] | "Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors." Jordan P., Brazao R., Boavida M.G., Gespach C., Chastre E. Oncogene 18:6835-6839(1999) [PubMed: 10597294] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B). Tissue: Colon and Skin. |
| [5] | "Mutations and altered expression of Rac1 in human breast cancer --characterization of a new Rac1 isoform, Rac1ins." Schnelzer A., Knaus U., Prechtel D., Dehne K., Harbeck N., Gerhard M., Schmitt M., Lengyel E. Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B). |
| [6] | "Identification of a human migration-inducing gene." Kim J.W. Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A). |
| [7] | "cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org)." Puhl H.L. III, Ikeda S.R., Aronstam R.S. Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A), VARIANT ILE-135. |
| [8] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A). |
| [9] | "NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu)." Livingston R.J., Rieder M.J., Shaffer T., Bertucci C., Baier C.N., Rajkumar N., Willa H.T., Daniels M., Downing T.K., Stanaway I.B., Nguyen C.P., Gildersleeve H., Cassidy C.M., Johnson E.J., Swanson J.E., McFarland I., Yool B., Park C., Nickerson D.A. Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [10] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed: 12853948] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [11] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A). Tissue: Pancreas and Skin. |
| [12] | "Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA." Kinsella B.T., Erdman R.A., Maltese W.A. J. Biol. Chem. 266:9786-9794(1991) [PubMed: 1903399] [Abstract] Cited for: ISOPRENYLATION AT CYS-189. |
| [13] | "The small GTP-binding protein rac regulates growth factor-induced membrane ruffling." Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., Hall A. Cell 70:401-410(1992) [PubMed: 1643658] [Abstract] Cited for: FUNCTION. |
| [14] | "Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity." Jullien-Flores V., Dorseuil O., Romero F., Letourneur F., Saragosti S., Berger R., Tavitian A., Gacon G., Camonis J.H. J. Biol. Chem. 270:22473-22477(1995) [PubMed: 7673236] [Abstract] Cited for: INTERACTION WITH RALBP1. |

Clusters with